| Name | Count |
|---|
..., such as Endo Pharmaceuticals, which has a generic component and also focuses on pain management. Van...
... relationship between neuropsychiatric events and two other drugs, Endo Pharmaceuticals Inc.’s Symmetrel and...
... Holdings Inc. and Penwest Pharmaceuticals Co. over the pain reliever Opana ER. The lawsuit, filed in the...
...,” the SEC said. For example, in July 2003, Colonial bought 202,000 shares of Endo Pharmaceutical...
... patent's enforceability, the court will draw on the record of an earlier patent dispute with Endo...
... Endo Pharmaceuticals, which had challenged the company’s patents for the drug. In June 2005, the...
... Roxane Laboratories Inc., Endo Pharmaceuticals Inc. Teva Pharmaceuticals USA Inc., Impax Laboratories Inc...
... lawsuit—including Chiron Corp., Eli Lilly & Co., Endo Pharmaceuticals Inc., Amgen Inc., Barr Laboratories Inc. and...
... Massachusetts district court Friday from Chiron Corp., Eli Lilly & Co., Endo Pharmaceuticals Inc., Amgen Inc...
... trial on patent infringement claims made by Purdue against Endo Pharmaceuticals Inc., which sought U.S...
... potential rivals (including Roxane Laboratories Inc., Endo Pharmaceuticals Inc. Teva Pharmaceuticals USA...
... Southern District of New York to decide the fate of the patent battle waged between Purdue and Endo...
... decide the fate of the patent battle waged between Purdue and Endo Pharmaceuticals, which had challenged...
... another patent infringement suit over generic versions of OxyContin, stipulating that generic maker Endo...
... on patent infringement claims made by Purdue against Endo Pharmaceuticals Inc., which sought U.S...
... clients have included companies such as Honeywell International Inc., Endo Pharmaceuticals Inc., Valeant...
... company’s revenue. Purdue reached settlements with Teva Pharmaceuticals Industries Ltd. and Endo...
... copycat version of OxyContin. The settlement with generic maker Endo Pharmaceuticals stipulated that Endo...
... settlements receive antitrust approval. Endo Pharmaceuticals has agreed to end its patent infringement...
...Endo Pharmaceuticals’ risk-fraught decision to continue marketing its generic version of painkiller...